Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal Vaccines in HIV-Infected Pregnant Women
NCT01443117Phase 2Withdrawn
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Aug 2014
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 2 trial of pneumococcal 13-valent conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine in pneumococcal infection, sponsored by National Institute of Allergy and Infectious Diseases. Status: withdrawn.
02
Drugs
pneumococcal 13-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01443117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01443117.